LINC02306

Across TCGA pan-cancer cohorts, LINC02306 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC02306’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02306 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02306 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

KIRC, LUSC, and THCA are the cancer types where LINC02306 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02306 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	−0.085	<.001	7	view →
LUSC	All	All	+0.094	.001	3	view →
THCA	All	All	+0.159	.023	2	view →
LUAD	All	All	+0.104	.008	2	view →
STAD	All	All	+0.075	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC02306–KIRC

Open the KIRC breakdown →